Navigation Links
Inovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014
Date:8/1/2014

rsity of Manitoba. For more information, visit www.inovio.com.

This press release contains certain forward-looking statements relating to our business, including our plans to develop electroporation-based drug and gene delivery technologies and DNA vaccines and our capital resources. Actual events or results may differ from the expectations set forth herein as a result of a number of factors, including uncertainties inherent in pre-clinical studies, clinical trials and product development programs (including, but not limited to, the fact that pre-clinical and clinical results referenced in this release may not be indicative of results achievable in other trials or for other indications, that the studies or trials may not be successful or achieve the results desired, including safety and efficacy for VGX-3100, that pre-clinical studies and clinical trials may not commence or be completed in the time periods anticipated, that results from one study may not necessarily be reflected or supported by the results of other similar studies and that results from an animal study may not be indicative of results achievable in human studies), the availability of funding to support continuing research and studies in an effort to prove safety and efficacy of electroporation technology as a delivery mechanism or develop viable DNA vaccines, our ability to support our broad pipeline of SynCon® active immune therapy and vaccine products, the adequacy of our capital resources, the availability or potential availability of alternative therapies or treatments for the conditions targeted by the company or its collaborators, including alternatives that may be more efficacious or cost-effective than any therapy or treatment that the company and its collaborators hope to develop, evaluation of potential opportunities, issues involving product liability, issues involving patents and whether they or licenses to them will pro
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II Cervical Dysplasia Trial
2. Inovio Pharmaceuticals to Present at Biotech Showcase 2014 Investor Conference
3. CEO Dr. Joseph Kim to Discuss Inovios Innovative Approach to Treating Cervical Cancer in an Expert Panel
4. Inovio Pharmaceuticals Reports 2013 Third Quarter Financial Results
5. Inovio Pharmaceuticals Therapeutic Vaccine for Hepatitis C Enters Phase I Clinical Trial
6. Inovio Pharmaceuticals to Participate in Immunotherapy Panel and Present at the 12th Annual BIO Investor Forum
7. Inovio Pharmaceuticals Targets Transformation of Monoclonal Antibody Therapies
8. Inovio Pharmaceuticals to Present at Investor Conferences and Town Hall Los Angeles
9. Roche and Inovio Pharmaceuticals partner on Inovios prostate cancer and hepatitis B immunotherapy products
10. Inovio Pharmaceuticals to Present at Upcoming Investor Conferences
11. Inovio Pharmaceuticals Malaria DNA Vaccine Demonstrates Robust Immune Responses in Animal Models
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2015)... NASHVILLE, Tenn. , April 30, 2015  Cumberland ... it will release first quarter 2015 financial results after ... conference call and live Internet webcast will be held ... Time to discuss the results. To participate ... or 253-237-1032 (for international callers).  A rebroadcast of the ...
(Date:4/30/2015)... 2015  Nektar Therapeutics (Nasdaq: NKTR ) today ... March 31, 2015. Cash and investments ... million as compared to $262.8 million at December 31, ... March 31, 2015 includes a $100.0 million milestone payment ... commercial sale of Movantik™(naloxegol) in the U.S. ...
(Date:4/30/2015)... plc (NYSE: PRGO ; TASE) today announced that Perrigo Chairman, ... the 2015 Deutsche Bank 40 th Annual Healthcare Conference at ... in Boston , MA.  The ... C. Papa will present at the Bank of America Merrill ... 2015 at the Encore at Wynn Las Vegas Hotel in ...
Breaking Medicine Technology:Cumberland Pharmaceuticals To Announce First Quarter 2015 Financial Results 2Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 2Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 3Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 4Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 5Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 6Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 7Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 8Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 9Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 10Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 11Nektar Therapeutics Reports Financial Results for the First Quarter of 2015 12Perrigo Company To Present At Upcoming Healthcare Conferences 2Perrigo Company To Present At Upcoming Healthcare Conferences 3
... Therapeutics, Inc. ("CTI") (Nasdaq and MTA: CTIC) today announced that ... New Drugs ("OND") in Maryland and presented its arguments supporting ... Drug Application ("NDA") 22-481 support the conclusion that pixantrone is ... consideration of our appeal.  While we understand disputes of this ...
... SQNM ), today announced the awards of non-qualified ... common stock for six new employees under the company,s New ... Of these shares, 14,450 have an exercise price ... Sequenom,s common stock on February 28, and 60,000 have a ...
Cached Medicine Technology:FDA's Office of New Drugs Meets With Cell Therapeutics on its Appeal on Pixantrone 2FDA's Office of New Drugs Meets With Cell Therapeutics on its Appeal on Pixantrone 3Sequenom Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 2Sequenom Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 3
(Date:5/2/2015)... Ohio (PRWEB) May 02, 2015 On ... Liverpool City Hospital (ELCH) gathered to celebrate improvements in ... River Valley Health Partners (RVHP), had zero acquired ventilator ... urinary catheter associated infections. ELCH was also recently named ... The management team at ELCH credited the teamwork of ...
(Date:5/1/2015)... Frisco, Texas (PRWEB) May 02, 2015 ... Frisco, Texas, is proud to announce the addition of ... Jen Widerstrom is a life long athlete, growing up ... fitness passion after college by becoming a personal trainer ... since been the face of several TV shows highlighting ...
(Date:5/1/2015)... Va. (PRWEB) May 01, 2015 The ... nation’s leading nonprofit authority on the use of health ... as a key contributing resource to the United States ... use of electronically readable cards in Medicare. The report, ... and Providers ” was released to the public on ...
(Date:5/1/2015)... Linda, CA (PRWEB) May 01, 2015 ... our genetic makeup and the interplay of genes with ... up with developments can be daunting. , LabRoots, the ... and clinical diagnostics professionals, will soon host its annual ... , At BioConference Live Genetics and Genomics 2015 ...
(Date:5/1/2015)... May 01, 2015 The frozen yogurt ... the Hickory Crawdads (NC) and the Myrtle Beach Pellicans ... in-stadium concession locations and offer fans discounts at local ... the Hickory Community,” said Luke Shook, co-owner of the ... opportunity and we look forward to enjoying the games ...
Breaking Medicine News(10 mins):Health News:East Liverpool City Hospital Celebrates Patient Care Improvements 2Health News:IDLife LLC Announces New Partnership with Fitness Celebrity, Jen Widerstrom 2Health News:WEDI Contributes to Newly Released U.S. Government Accountability Office (GAO) Study on Potential Use of Electronically Readable Medicare Cards 2Health News:WEDI Contributes to Newly Released U.S. Government Accountability Office (GAO) Study on Potential Use of Electronically Readable Medicare Cards 3Health News:Recent Advances in Genetics and Genomics: A BioConference Live 2015 Virtual Event 2Health News:Recent Advances in Genetics and Genomics: A BioConference Live 2015 Virtual Event 3Health News:sweetFrog Announces Minor League Baseball Partnerships 2
... cancer treatment, chemobrain a range of symptoms including ... subtle cognitive changes following chemotherapy seriously diminishes women,s ... they have to adopt a range of coping strategies ... Breast cancer survivors tell their story in a ...
... , SAN DIEGO, Sept. 17 ... that the company,s first laboratory developed test, the SensiGene(TM) Cystic ... is available exclusively through the Sequenom Center for Molecular Medicine, ... laboratory and a wholly-owned subsidiary of Sequenom, Inc. , ...
... Office of Minority Health Urges "Know Your Risk and Help ... 17 Speaking at the Venous Disease Coalition (VDC) Annual Meeting ... the Department of Health and Human Services followed up on last ... African American population which is at significantly increased risk of Deep ...
... , DALLAS, Sept. 17 The Texas ... released its annual report on the prevalence, cost and quality ... includes information for key local markets across the state including ... Also included are state and national benchmarks that can help ...
... set by CDC need to be lowered, experts say , ... levels well below those considered safe are still at risk ... , Currently, the maximum safe blood level of lead is ... the U.S. Centers for Disease Control and Prevention in 1991. ...
... ... communications company. , ... Knoxville, TN (PRWeb) Sept. 17, 2009 -- Alan Weinstein was recently named chairman of ... innovative ways to leverage PerfectServe,s physician-contact network serving physician practices and hospitals nationwide. , ...
Cached Medicine News:Health News:Chemobrain -- the flip side of surviving cancer 2Health News:SEQUENOM Announces Launch of SensiGene Cystic Fibrosis Carrier Screening Test 2Health News:SEQUENOM Announces Launch of SensiGene Cystic Fibrosis Carrier Screening Test 3Health News:SEQUENOM Announces Launch of SensiGene Cystic Fibrosis Carrier Screening Test 4Health News:SEQUENOM Announces Launch of SensiGene Cystic Fibrosis Carrier Screening Test 5Health News:SEQUENOM Announces Launch of SensiGene Cystic Fibrosis Carrier Screening Test 6Health News:African Americans at Significantly Higher Risk of DVT or Blood Clots 2Health News:African Americans at Significantly Higher Risk of DVT or Blood Clots 3Health News:African Americans at Significantly Higher Risk of DVT or Blood Clots 4Health News:TBGH Report on Status of Diabetes in Texas Indicates Growing Severity of Problem and Higher Cost of Care Than National Average 2Health News:TBGH Report on Status of Diabetes in Texas Indicates Growing Severity of Problem and Higher Cost of Care Than National Average 3Health News:TBGH Report on Status of Diabetes in Texas Indicates Growing Severity of Problem and Higher Cost of Care Than National Average 4Health News:Even Small Amounts of Lead Harmful to Kids 2Health News:Even Small Amounts of Lead Harmful to Kids 3Health News:Alan Weinstein Named Chairman of PerfectServe Advisory Board 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: